According to the SEC Form 4 filings, Alkire Michael J., being in a position of
No biography is available at this moment.
Buys | $0 | 0 | 0 |
Sells | $1,605,023 | 6 | 100 |
| 2025-09-05 | Sale | AppLovin Corporation APP | director | 350 0.0001% | $487.97 | $170,790 | +0.47% | |
| 2025-09-05 | Sale | Ares Management Corporation ARES | Co-Founder & Exec. Chairman | 176,784 0.0818% | $177.05 | $31.3M | +0.14% | |
| 2025-09-05 | Sale | Avista Corporation AVA | Vice President | 1,367 0.0017% | $36.72 | $50,196 | +0.41% | |
| 2025-09-05 | Sale | Axsome Therapeutics, Inc. AXSM | director | 9,127 0.0183% | $125.07 | $1.14M | +0.08% | |
| 2025-09-05 | Blink Charging Co. BLNK | Chief Financial Officer | 6,000 0.0059% | $1.02 | $6,144 | -0.39% | ||
| 2025-09-05 | Sale | Brixmor Property Group Inc. BRX | See remarks | 25,000 0.0082% | $28.21 | $705,250 | -0.04% | |
| 2025-09-05 | First Busey Corporation BUSE | President | 7,960 – | $25.44 | $202,502 | -2.99% | ||
| 2025-09-05 | Bankwell Financial Group, Inc. BWFG | director | 180 0.0023% | $42.53 | $7,655 | +1.29% | ||
| 2025-09-05 | Sale | Cogent Communications Holdings, Inc. CCOI | VP OF NETWORK STRATEGY | 2,400 0.0049% | $36.99 | $88,776 | -0.3% | |
| 2025-09-05 | The Cooper Companies, Inc. COO | President, CooperVision, Inc. | 1,450 0.0007% | $69.23 | $100,384 | -1.65% | ||
| 2025-09-05 | The Cooper Companies, Inc. COO | President & CEO | 10,000 0.005% | $68.39 | $683,900 | -0.44% | ||
| 2025-09-05 | Sale | Centuri Holdings, Inc. CTRI | 10 percent owner | 27.36M 28.0208% | $19.60 | $536.3M | +10.15% | |
| 2025-09-05 | Sale | Cousins Properties Incorporated CUZ | SVP, Chief Accounting Officer | 4,612 0.0027% | $29.30 | $135,132 | +0.58% | |
| 2025-09-05 | Sale | Noble Corporation Plc NE | SVP, Operations | 35,000 0.0221% | $28.62 | $1M | -0.07% | |
| 2025-09-05 | Sale | QCR Holdings, Inc. QCRH | President & CEO, QCBT | 333 0.002% | $80.00 | $26,640 | -2.06% | |
| 2025-09-05 | Sale | Arcus Biosciences, Inc. RCUS | Chief Accounting Officer | 1,579 0.0014% | $11.88 | $18,758 | +2.61% | |
| 2025-09-05 | Sale | Avidity Biosciences, Inc. RNA | President and CEO | 50,000 0.0385% | $49.95 | $2.5M | +0.82% | |
| 2025-09-05 | Sale | Roivant Sciences Ltd. ROIV | 10 percent owner | 385,816 0.0567% | $12.96 | $5M | -0.31% | |
| 2025-09-05 | Safety Insurance Group, Inc. SAFT | director | 2,000 0.0134% | $72.39 | $144,780 | +0.26% | ||
| 2025-09-05 | Sale | Sera Prognostics, Inc. SERA | director | 222 0.0006% | $3.35 | $744 | -0.3% |